Pegasys subcutaneous injection 180 μg, manufactured by Chugai Pharmaceutical, contains Peginterferon alpha-2a (genetical recombination). This injectable drug (YJ code: 6399419A2029) is supplied as 180μg in 1mL per bottle and is used to treat chronic hepatitis B and C by helping the immune system fight the viruses.
Pegasys subcutaneous injection 180 μg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).